Direktorat Registrasi ObatValid

TAMIFLU

BPOM Number: DKI2157510401A1
Approved: 21 November 2024
Expiry: 3 January 2027
Form: KAPSUL; 98,5 MG

About This Registration

TAMIFLU is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2157510401A1. Its current registration status is Valid, with the licence valid until 3 January 2027. The product is registered to MENARINI INDRIA LABORATORIES - INDONESIA. BPOM first approved this registration in January 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS,1 BLISTER @ 10 KAPSUL
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MENARINI INDRIA LABORATORIES - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

MENARINI INDRIA LABORATORIES - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

OSELTAMIVIR PHOSPHATE

Market Intelligence

Owner Portfolio: MENARINI INDRIA LABORATORIES - INDONESIA holds 98 BPOM registrations
Manufacturer Scale: MENARINI INDRIA LABORATORIES - INDONESIA produces 98 registered products
Registration Age: Registered for 4 years, 8 months
Expiry Status: Expires in 3 months

FDA Cross-Reference

via openFDA

Generic Name: OSELTAMIVIR PHOSPHATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?